Stay updated on Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now includes updated information about Seagen, a subsidiary of Pfizer, and a new date of February 19, 2025, while the previous date of February 3, 2025, has been removed.
    Difference
    8%
    Check dated 2025-02-24T19:06:38.000Z thumbnail image
  5. Check
    33 days ago
    No Change Detected
  6. Check
    41 days ago
    Change Detected
    Summary
    The webpage now includes a notice about heavy traffic affecting NLM-NCBI services and products, along with a contact for assistance. Additionally, a date has been updated from September 4, 2024, to February 3, 2025.
    Difference
    7%
    Check dated 2025-02-10T09:24:07.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T05:06:40.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-19T19:28:26.000Z thumbnail image
  9. Check
    69 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    1.0%
    Check dated 2025-01-12T16:19:12.000Z thumbnail image
  10. Check
    98 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T12:12:33.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial page.